Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 21
- CBD Market
ACCESS CBD voted UK’s best CBD oil in pharmacy sector for sleep, stress and insomnia
The MVP Pharmacy Awards took place in November 2022 at a prestigious London venue – seeing the biggest manufacturers in the industry gather for a blend of dining and bowling in the hope of seeing their product crowned Most Valuable Product.
- Companies
Linnea to expand high THC exports with Swiss licence
Linnea will begin producing GMP-certified high-THC APIs in 2023.
- CBD Market
UK CBD and wellness startup wins major online contracts
Healthy Body Healthy Mind (HBHM) secured contracts with two major online retailers – Amazon and Not on the High Street – for the sale and distribution of their range of CBD oils.
- CBD Market
Naturecan hits more than £11m in sales in 2022
The CBD health business was founded by former Myprotein boss Andy Duckworth.
- Companies
Celadon granted MHRA GMP certification for cannabis API
The UK-based pharmaceutical company has stated that the registration follows seven harvests and extractions and an MHRA inspection in 2022.
- Companies
Apollon Formularies and Global Hemp Group sign Letter of Intent
UK-based Apollon Formularies and Global Hemp Group (GHG) have signed a Letter of Intent GHG will acquire the exclusive perpetual license for North America to certain Apollon Intellectual Property and proprietary technology.
- CBD Market
UK company granted ethics approval for CBD trial
The company has received Ethics Approval from Bellberry Human Research Ethics Committee in Australia.
- Companies
Khiron secures first cannabis insurance contract in Colombia
The company has won the contract following the country’s announcement that insurance for medical cannabis will be mandatory.
- CBD Market
Kardashian-backed CBD brand to launch in Europe
Ambrani CBD is expanding its distribution to the continent with a focus on brick-and-mortar retail in Germany.
- Adult-Use
Flora Growth confirms direct distribution lines to Europe
Flora Growth has provided an update to its international commercial cannabis export business.
- Pharmaceutical
Clinical trial application submitted to MHRA for cannabinoid medicine
The application has been submitted in preparation for a review.
- CBD Market
France ends ban on sale of CBD flowers
French cannabis industry representatives have welcomed the news, stating the industry will now be able to flourish in the country.
